Bioventix PLC (BVXP.L)
ValueMarkers Composite Index
54% below intrinsic value ($56)
Bioventix PLC (BVXP.L) — VMCI valuation read
BVXP.L prints VMCI 58/100 inside the Healthcare sector, where the median sits at 50. The 8-point above-median delta is the cleanest single-number summary of Bioventix PLC's composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.
On BVXP.L, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.
**Investor frame.** BVXP.L trades at 20.0x earnings, 11% above the Healthcare median of 18.0x; that is the value line. ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 3.3x is the binding constraint on the bear case; that is the risk line for Bioventix PLC on the trailing financials.
BVXP.L fell 2.0% over the trailing 7 days, with a +2.0% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.